These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 8993775)
1. Influence of a DLE-extracted lymphocytic suppressor factor on CsA-induced immunosuppression. Rosso di San Secondo VE; Aniasi A; Piccolo G; Montecucchi PC; Sirchia G Biotherapy; 1996; 9(1-3):159-62. PubMed ID: 8993775 [TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus. Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092 [TBL] [Abstract][Full Text] [Related]
3. Potentiation of cyclosporine A-induced immunosuppression by a lymphocytic low-molecular weight peptide. Rosso di San Secondo VE; Aniasi A; Piccolo G; Montecucchi PC; Sirchia G Transplant Proc; 1994 Dec; 26(6):3221-2. PubMed ID: 7998122 [No Abstract] [Full Text] [Related]
4. The effect of immunosuppressive drug cyclosporine A on myeloid-derived suppressor cells in transplanted mice. Han C; Wu T; Na N; Zhao Y; Li W; Zhao Y Inflamm Res; 2016 Sep; 65(9):679-88. PubMed ID: 27147271 [TBL] [Abstract][Full Text] [Related]
5. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin. Dono K; Maki T; Wood ML; Monaco AP Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521 [TBL] [Abstract][Full Text] [Related]
6. Intracerebral xenotransplantation of GFP mouse bone marrow stromal cells in intact and stroke rat brain: graft survival and immunologic response. Irons H; Lind JG; Wakade CG; Yu G; Hadman M; Carroll J; Hess DC; Borlongan CV Cell Transplant; 2004; 13(3):283-94. PubMed ID: 15191166 [TBL] [Abstract][Full Text] [Related]
7. Tepoxalin, a novel immunomodulatory compound, synergizes with CsA in suppression of graft-versus-host reaction and allogeneic skin graft rejection. Fung-Leung WP; Pope BL; Chourmouzis E; Panakos JA; Lau CY Transplantation; 1995 Aug; 60(4):362-8. PubMed ID: 7652766 [TBL] [Abstract][Full Text] [Related]
8. A novel immunosuppressant, IR-1116, which has a different biological mechanism from that of cyclosporine A. Matsumoto S; Marui S; Shiho O; Tsukamoto K; Yoshimura N; Oka T Eur J Immunol; 1993 Sep; 23(9):2121-8. PubMed ID: 8370395 [TBL] [Abstract][Full Text] [Related]
9. The immunopharmacology of immunosuppression by 15-deoxyspergualin. Yuh DD; Morris RE Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226 [TBL] [Abstract][Full Text] [Related]
11. Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy. Zhu P; Bailey SR; Lei B; Paulos CM; Atkinson C; Tomlinson S Transplantation; 2017 Apr; 101(4):e75-e85. PubMed ID: 28045880 [TBL] [Abstract][Full Text] [Related]
12. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function. Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344 [TBL] [Abstract][Full Text] [Related]
13. Effects of 15-deoxyspergualin on proliferative responses and cytokine gene expression in vitro. Imamura M; Zhu X; Hashino S; Han CW; Tanaka J; Kobayashi H; Imai K; Kasai M; Sakurada K; Miyazaki T Immunobiology; 1994 Dec; 192(1-2):24-39. PubMed ID: 7750988 [TBL] [Abstract][Full Text] [Related]
14. Tumor-derived suppressor factors (TDSFs) in normal and neoplastic colon and rectum. Hoagland JG; Scoggin S; Giavazzi R; Campbell D; Kanellopoulos K; Jessup JM J Surg Res; 1986 May; 40(5):467-74. PubMed ID: 2942730 [TBL] [Abstract][Full Text] [Related]
15. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice. Tu Y; Stepkowski SM; Chou TC; Kahan BD Transplantation; 1995 Jan; 59(2):177-83. PubMed ID: 7839437 [TBL] [Abstract][Full Text] [Related]
16. The immunosuppressive action of suppressor cells from antigen-cyclosporine-treated hosts on renal allograft survival. Yoshimura N; Kahan BD Transplantation; 1985 Oct; 40(4):384-9. PubMed ID: 2413593 [TBL] [Abstract][Full Text] [Related]
17. Seasonal influence on mitogen and cyclosporin responses of peripheral blood lymphocytes. Michelis FV; Delitheos AK; Tiligada E Int Immunopharmacol; 2013 Jun; 16(2):154-9. PubMed ID: 23562756 [TBL] [Abstract][Full Text] [Related]
18. Interference with cyclophosphamide-induced skin allograft tolerance by cyclosporin A. Nomoto K; Eto M; Yanaga K; Nishimura Y; Maeda T; Nomoto K J Immunol; 1992 Oct; 149(8):2668-74. PubMed ID: 1401906 [TBL] [Abstract][Full Text] [Related]
19. Development of TCR-gamma delta CD4-CD8+ alpha alpha but not TCR-alpha beta CD4-CD8+ alpha alpha i-IEL is resistant to cyclosporin A. Lin T; Matsuzaki G; Umesue M; Omoto K; Yoshida H; Harada M; Singaram C; Hiromatsu K; Nomoto K J Immunol; 1995 Nov; 155(9):4224-30. PubMed ID: 7594578 [TBL] [Abstract][Full Text] [Related]
20. Effects of cyclosporin A on IL-2 production and lymphocyte proliferation during infection of mice with lymphocytic choriomeningitis virus. Kasaian MT; Biron CA J Immunol; 1990 Jan; 144(1):299-306. PubMed ID: 1967265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]